# EDGAR Filing Document

**Accession Number:** 0001665650
**File Stem:** 0001839882-26-012635
**Filing Date:** 2026-3
**Character Count:** 94501
**Document Hash:** ec2c80f426afd686b91258304f5b5ab0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001839882-26-012635.hdr.sgml**: 20260302

**ACCESSION NUMBER**: 0001839882-26-012635

**CONFORMED SUBMISSION TYPE**: 424B2

**PUBLIC DOCUMENT COUNT**: 12

**FILED AS OF DATE**: 20260302

**DATE AS OF CHANGE**: 20260302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270004
- **FILM NUMBER:** 26709596

**BUSINESS ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMorgan Chase Financial Co. LLC
- **CENTRAL INDEX KEY:** 0001665650
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 475462128
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270004-01
- **FILM NUMBER:** 26709597

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** (212) 270-6000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; This term sheet, which is not complete and may be changed, relates to an effective Registration Statement under the Securities Act of 1933. This term sheet and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these notes in any country or jurisdiction where such an offer would not be permitted. | &nbsp;&nbsp;&nbsp; This term sheet, which is not complete and may be changed, relates to an effective Registration Statement under the Securities Act of 1933. This term sheet and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these notes in any country or jurisdiction where such an offer would not be permitted. |
| &nbsp;&nbsp; **Subject to Completion**<br> **Preliminary Term Sheet** <br> **dated March 2, 2026** | &nbsp;&nbsp; **Filed Pursuant to Rule 424(b)(2)**<br> **Registration Statement Nos. 333-270004 and 333-270004-01**<br> **(To Prospectus dated April 13, 2023, Prospectus Supplement dated April 13, 2023, Prospectus Addendum dated June 3, 2024 and Product Supplement EQUITY MLI-1 dated August 6, 2024)** |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Units<br>$10 principal amount per unit<br>CUSIP No. 48134L770 | &nbsp;&nbsp;&nbsp;&nbsp; Pricing Date\*<br>Settlement Date\*<br>Maturity Date\* | &nbsp;&nbsp; March , 2026<br>March , 2026<br>March , 2029 |
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Units<br>$10 principal amount per unit<br>CUSIP No. 48134L770 | &nbsp;&nbsp;&nbsp;&nbsp; \*Subject to change based on the actual date the notes are priced for initial sale to the public (the "pricing date") | &nbsp;&nbsp;&nbsp;&nbsp; \*Subject to change based on the actual date the notes are priced for initial sale to the public (the "pricing date") |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **JPMorgan Chase Financial Company LLC**<br> **Leveraged Index Return Notes**<sup>®</sup> **Linked to the Worst-Performing of the EURO STOXX 50**<sup>®</sup> **Index and the Swiss Market Index**<br> **Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.**<br> ￭Maturity of approximately three years<br> ￭[230.00% to 255.00%] leveraged upside exposure to increases in the Worst-Performing Market Measure, which will be one of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index (each, an "Index," and, collectively, the "Indices")<br> ￭If the Worst-Performing Market Measure declines, but not by more than 20.00%, a return of principal<br> ￭1-to-1 downside exposure to decreases in the Worst-Performing Market Measure beyond a 20.00% decline, with up to 80.00% of your principal at risk<br> ￭The notes are not linked to a basket composed of the Market Measures. Any depreciation in the level of either Market Measure will not be offset by any appreciation in the level of the other Market Measure<br> ￭All payments occur at maturity and are subject to the credit risk of JPMorgan Chase Financial Company LLC, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes<br> ￭No periodic interest payments<br> ￭Investors in the notes should be willing to forgo dividend and interest payments and will be willing to accept the risk of losing some or all of their principal amount at maturity<br> ￭Limited secondary market liquidity, with no exchange listing<br> ￭The notes will be issued in denominations of whole "units". Each unit will have a principal amount of $10. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **JPMorgan Chase Financial Company LLC**<br> **Leveraged Index Return Notes**<sup>®</sup> **Linked to the Worst-Performing of the EURO STOXX 50**<sup>®</sup> **Index and the Swiss Market Index**<br> **Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.**<br> ￭Maturity of approximately three years<br> ￭[230.00% to 255.00%] leveraged upside exposure to increases in the Worst-Performing Market Measure, which will be one of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index (each, an "Index," and, collectively, the "Indices")<br> ￭If the Worst-Performing Market Measure declines, but not by more than 20.00%, a return of principal<br> ￭1-to-1 downside exposure to decreases in the Worst-Performing Market Measure beyond a 20.00% decline, with up to 80.00% of your principal at risk<br> ￭The notes are not linked to a basket composed of the Market Measures. Any depreciation in the level of either Market Measure will not be offset by any appreciation in the level of the other Market Measure<br> ￭All payments occur at maturity and are subject to the credit risk of JPMorgan Chase Financial Company LLC, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes<br> ￭No periodic interest payments<br> ￭Investors in the notes should be willing to forgo dividend and interest payments and will be willing to accept the risk of losing some or all of their principal amount at maturity<br> ￭Limited secondary market liquidity, with no exchange listing<br> ￭The notes will be issued in denominations of whole "units". Each unit will have a principal amount of $10. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **JPMorgan Chase Financial Company LLC**<br> **Leveraged Index Return Notes**<sup>®</sup> **Linked to the Worst-Performing of the EURO STOXX 50**<sup>®</sup> **Index and the Swiss Market Index**<br> **Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.**<br> ￭Maturity of approximately three years<br> ￭[230.00% to 255.00%] leveraged upside exposure to increases in the Worst-Performing Market Measure, which will be one of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index (each, an "Index," and, collectively, the "Indices")<br> ￭If the Worst-Performing Market Measure declines, but not by more than 20.00%, a return of principal<br> ￭1-to-1 downside exposure to decreases in the Worst-Performing Market Measure beyond a 20.00% decline, with up to 80.00% of your principal at risk<br> ￭The notes are not linked to a basket composed of the Market Measures. Any depreciation in the level of either Market Measure will not be offset by any appreciation in the level of the other Market Measure<br> ￭All payments occur at maturity and are subject to the credit risk of JPMorgan Chase Financial Company LLC, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes<br> ￭No periodic interest payments<br> ￭Investors in the notes should be willing to forgo dividend and interest payments and will be willing to accept the risk of losing some or all of their principal amount at maturity<br> ￭Limited secondary market liquidity, with no exchange listing<br> ￭The notes will be issued in denominations of whole "units". Each unit will have a principal amount of $10. |

---

**The notes are being issued by JPMorgan Chase Financial Company LLC ("JPMorgan Financial") and are fully and unconditionally guaranteed by JPMorgan Chase & Co. Investing in the notes involves a number of risks. There are important differences between the notes and a conventional debt security, including different investment risks and certain additional costs. See "Risk Factors" beginning on page TS-7 of this term sheet, "Additional Risk Factor" on page TS-9 of this term sheet, and "Risk Factors" on page PS-6 of the accompanying product supplement, page S-2 of the accompanying prospectus supplement and Annex A of the accompanying prospectus addendum.** 

**The initial estimated value of the notes, when the terms of the notes are set, will be provided in the final term sheet and is expected to be between $9.40 and $9.618 per unit, which is less than the public offering price listed below.** See "Summary" on the following page, "Risk Factors" beginning on page TS-7 of this term sheet and "The Estimated Value of the Notes" on page TS-12 of this term sheet for additional information. The actual value of your notes at any time will reflect many factors and cannot be predicted with accuracy.

**_________________________**

None of the Securities and Exchange Commission (the "SEC"), any state securities commission, or any other regulatory body has approved or disapproved of these securities or determined if this Note Prospectus (as defined below) is truthful or complete. Any representation to the contrary is a criminal offense.

**_________________________**

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp; <u>Per</u> <u>Unit</u> | &nbsp;&nbsp; <u>Total</u> |
| &nbsp;&nbsp; Public offering price | $&nbsp;&nbsp; 10.00 | &nbsp;&nbsp; $ |
| &nbsp;&nbsp; Underwriting discount<sup>(1)</sup> | $&nbsp;&nbsp; 0.175 | &nbsp;&nbsp; $ |
|  | $&nbsp;&nbsp; 0.05 |  |
| &nbsp;&nbsp; Proceeds, before expenses, to JPMorgan Financial | $&nbsp;&nbsp; 9.775 | &nbsp;&nbsp; $ |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The underwriting discount reflects a sales commission of $0.175 per unit and a structuring fee of $0.05.

**The notes and the related guarantee:**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Are Not FDIC Insured** | &nbsp;&nbsp; **Are Not Bank Guaranteed** | &nbsp;&nbsp; **May Lose Value** |

---

**J.P. Morgan Securities LLC**

March , 2026

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Summary

The Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 (the "notes") are our unsecured and unsubordinated obligations. Payments on the notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes and the related guarantee are not insured by the Federal Deposit Insurance Corporation or secured by collateral. **The notes will rank equally in right of payment with all other unsecured and unsubordinated obligations of JPMorgan Financial from time to time outstanding. The guarantee of the notes will rank equally in right of payment with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co., except obligations that are subject to any priorities or preferences by law, and senior in right of payment to its subordinated obligations. Any payments due on the notes, including any repayment of principal, will be subject to the credit risk of JPMorgan Financial, as issuer, and JPMorgan Chase & Co., as guarantor.** 

The notes provide you a leveraged return if the Ending Value of the Worst-Performing Market Measure, which will be one of the EURO STOXX 50<sup>®</sup> Index or the Swiss Market Index (as described in "Terms of the Notes" below) is greater than its Starting Value. If the Ending Value of the Worst-Performing Market Measure is equal to or less than its Starting Value but greater than or equal to its Threshold Value, you will receive the principal amount of your notes. If the Ending Value of the Worst-Performing Market Measure is less than its Threshold Value, you will lose a portion, which could be significant, of the principal amount of your notes. Any payments on the notes will be calculated based on the $10 principal amount per unit and will depend on the performance of the of the Worst-Performing Market Measure, subject to our and JPMorgan Chase & Co.'s credit risk. See "Terms of the Notes" below.

On the cover page of this term sheet, we have provided the initial estimated value range for the notes. This initial estimated value range was determined based on our, JPMorgan Chase & Co.'s and our other affiliates' pricing models, which take into consideration JPMorgan Chase & Co.'s internal funding rate and the market prices for the hedging arrangements related to the notes. The initial estimated value of the notes calculated on the pricing date will be set forth in the final term sheet made available to investors in the notes.

The estimated value of the notes set forth on the cover of this term sheet is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the notes. The internal funding rate used in the determination of the estimated value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates' view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the notes and any secondary market prices of the notes.

**Terms of the Notes**

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Issuer:** | &nbsp;&nbsp; JPMorgan Chase Financial Company LLC ("JPMorgan Financial"), a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. |
| &nbsp;&nbsp; **Guarantor:** | &nbsp;&nbsp; JPMorgan Chase & Co. |
| &nbsp;&nbsp; **Term:** | &nbsp;&nbsp; Approximately three years |
| &nbsp;&nbsp; **Market Measure:** | &nbsp;&nbsp; The Worst-Performing of the EURO STOXX 50<sup>®</sup> Index (Bloomberg symbol: "SX5E") and the Swiss Market Index (Bloomberg symbol: "SMI") (each an "Index," and collectively the "Indices") |
| &nbsp;&nbsp; **Worst-Performing Market Measure:** | &nbsp;&nbsp; The Index with the lowest Ending Value as compared to its Starting Value, calculated as follows:<br> With respect to each Index on the Final Calculation Day:<br> ![](image1.gif)  |
| &nbsp;&nbsp; **Principal Amount:** | &nbsp;&nbsp; $10.00 per unit |
| &nbsp;&nbsp; **Redemption Amount:** | &nbsp;&nbsp; On the maturity date the Issuer will pay, for each $10 of the outstanding principal amount, an amount in cash equal to:<br> ▪ If the Ending Value of the Worst-Performing Market Measure is greater than its Starting Value: <br> ![](image2.gif) <br> ▪ If the Ending Value of the Worst-Performing Market Measure is equal to or less than its Starting Value, but greater than or equal to its Threshold Value: $10<br> ▪ If the Ending Value of the Worst-Performing Market Measure is less than its Threshold Value:<br> ![](image3.gif)  |
| &nbsp;&nbsp; **Starting Value:** | &nbsp;&nbsp; With respect to each Index, its closing level on the Pricing Date |
| &nbsp;&nbsp; **Ending Value:** | &nbsp;&nbsp; With respect to each Index, its closing level on the Final Calculation Day |
| &nbsp;&nbsp; **Participation Rate:** | &nbsp;&nbsp; [230.00% to 255.00%]. The actual Participation Rate will be determined on the Pricing Date |
| &nbsp;&nbsp; **Threshold Value:** | &nbsp;&nbsp; With respect to each Index, 80.00% of its Starting Value (rounded to the nearest one-hundredth) |

---

<br> Leveraged Index Return Notes<sup>®</sup> TS-1

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Final Calculation Day / Maturity Valuation Period:** | &nbsp;&nbsp; March , 2029, which is the fifth scheduled Market Measure Business Day immediately preceding the maturity date, subject to postponement in the event of Market Disruption Events and non-Market Measure Business Days, as described beginning on page PS-30 of the accompanying product supplement |
| &nbsp;&nbsp; **Maturity Date:** | &nbsp;&nbsp; March , 2029, subject to postponement in the event of Market Disruption Events and non-Market Measure Business Days, as described beginning on page PS-30 of the accompanying product supplement |
| &nbsp;&nbsp; **Fees and Charges:** | &nbsp;&nbsp; The underwriting discount of $0.225 per unit listed on the cover page |
| &nbsp;&nbsp; **Calculation Agent:** | &nbsp;&nbsp; J.P. Morgan Securities LLC ("JPMS"), an affiliate of JPMorgan Financial |

---

<br> Leveraged Index Return Notes<sup>®</sup> TS-2

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

---

| |
|:---|
|  Redemption Amount Determination |
| &nbsp;&nbsp; On the maturity date, you will receive a cash payment per unit determined as follows: |

---

![](image4.gif)

<br> Leveraged Index Return Notes<sup>®</sup> TS-3

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

The terms and risks of the notes are contained in this term sheet and in the following:

￭Product supplement No. EQUITY MLI-1 dated August 6, 2024:

[<u>https://www.sec.gov/Archives/edgar/data/19617/000121390024065741/ea178829_424b2.pdf</u>](https://www.sec.gov/Archives/edgar/data/19617/000121390024065741/ea178829_424b2.pdf)

￭Prospectus supplement and prospectus, each dated April 13, 2023:<br>[<u>https://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf</u>](https://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf)

￭Prospectus addendum dated June 3, 2024:<br>[<u>http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm</u>](http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm)

These documents (together with this preliminary term sheet, the "Note Prospectus") have been filed as part of a registration statement with the SEC, which may, without cost, be accessed on the SEC website at www.sec.gov or obtained from Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S") by calling 1-800-294-1322. Before you invest, you should read the Note Prospectus, including this term sheet, for information about us, JPMorgan Chase & Co. and this offering. Any prior or contemporaneous oral statements and any other written materials you may have received are superseded by the Note Prospectus. Certain terms used but not defined in this term sheet have the meanings set forth in the accompanying product supplement. Unless otherwise indicated or unless the context requires otherwise, all references in this document to "we," "us," "our," or similar references are to JPMorgan Financial, and not to JPMorgan Chase & Co.

Investor Considerations

---

| | |
|:---|:---|
| &nbsp;&nbsp; **You may wish to consider an investment in the notes if:** | &nbsp;&nbsp; **The notes may not be an appropriate investment for you if:** |
| &nbsp;&nbsp; ￭You understand that any payment on the notes will be based solely on the performance of the Worst-Performing Market Measure.<br> ￭You anticipate that the value of the Worst-Performing Market Measure will increase from its Starting Value to its Ending Value.<br> ￭You are willing to risk a substantial loss of principal and return if the value of the Worst-Performing Market Measure decreases from its Starting Value to an Ending Value that is below its Threshold Value.<br> ￭You are willing to forgo the interest payments that are paid on conventional interest-bearing debt securities.<br> ￭You are willing to forgo dividends or other benefits of owning the stocks included in each Index.<br> ￭You are willing to accept a limited or no market for sales of the notes prior to maturity, and understand that the market prices for the notes, if any, will be affected by various factors, including our and JPMorgan Chase & Co.'s actual and perceived creditworthiness, JPMorgan Chase & Co.'s internal funding rate and fees and charges on the notes.<br> ￭You are willing to assume our credit risk, as issuer of the notes, and JPMorgan Chase & Co.'s credit risk, as guarantor of the notes, for all payments under the notes, including the Redemption Amount. | &nbsp;&nbsp; ￭You are unwilling to accept that any payment on the notes will be based solely on the performance of the Worst-Performing Market Measure, regardless of the performance of the other Index.<br> ￭You believe that the value of the Worst-Performing Market Measure will decrease from its Starting Value to its Ending Value or that it will not increase sufficiently over the term of the notes to provide you with your desired return.<br> ￭You seek 100% principal repayment or preservation of capital.<br> ￭You seek interest payments or other current income on your investment.<br> ￭You want to receive dividends or other distributions paid on the stocks included in any Index.<br> ￭You seek an investment for which there will be a liquid secondary market.<br> ￭You are unwilling or are unable to take market risk on the notes, to take our credit risk, as issuer of the notes, or to take JPMorgan Chase & Co.'s credit risk, as guarantor of the notes. |

---

We urge you to consult your investment, legal, tax, accounting, and other advisors before you invest in the notes.

<br> Leveraged Index Return Notes<sup>®</sup> TS-4

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Hypothetical Payout Profile and Examples of Payments at Maturity

The below graph is based on **hypothetical** numbers and values.

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Leveraged Index Return Notes**<sup>®</sup><br> ![](image5.gif)  | &nbsp;&nbsp; This graph reflects the hypothetical returns on the notes, based on a Participation Rate of 242.50% (the midpoint of the Participation Rate range) and the Threshold Value of 80.00% of the Starting Value of the Worst-Performing Market Measure. The green line reflects the return on the notes, while the dotted gray line reflects the return of a direct investment in the stocks included in the Worst-Performing Market Measure, excluding dividends.<br> This graph has been prepared for purposes of illustration only. |

---

The following table and examples are for purposes of illustration only. They are based on **hypothetical** values and show **hypothetical** returns on the notes. They illustrate the calculation of the Redemption Amount and total rate of return based on a hypothetical Starting Value of 100.00 for the Worst-Performing Market Measure, a Participation Rate of a hypothetical Threshold Value of 80.00 for the Worst-Performing Market Measure, a Participation Rate of 242.50% (the midpoint of the Participation Rate range), a Threshold Value of 80.00 for the Worst-Performing Market Measure and a range of hypothetical Ending Values of the Worst-Performing Market Measure. **The actual amount you receive and the resulting total rate of return will depend on the actual Starting Value, Ending Value and Threshold Value of each Index (in particular, of the Worst-Performing Market Measure), the actual Participation Rate and whether you hold the notes to maturity.** The following examples do not take into account any tax consequences from investing in the notes. The numbers appearing in the following table and in the examples below have been rounded for ease of analysis.

For recent actual levels of the Indices, see "The Indices" section below. Each Index is a price return index and as such the Ending Values will not include any income generated by dividends paid on the stocks included in the Indices, which you would otherwise be entitled to receive if you invested in those stocks directly. In addition, all payments on the notes are subject to issuer and guarantor credit risk.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp; **Ending Value of the Worst-<br>Performing Market <br>Measure** | &nbsp;&nbsp; **Percentage Change from the Starting Value <br>to the Ending Value of the Worst-Performing <br>Market Measure** | &nbsp;&nbsp; **Redemption <br>Amount per Unit**<sup>(1)</sup> | &nbsp;&nbsp; **Total Rate of Return on <br>the Notes** |
| &nbsp;&nbsp; 0.00 | &nbsp;&nbsp; -100.00% | &nbsp;&nbsp; $2.000 | &nbsp;&nbsp; -80.00% |
| &nbsp;&nbsp; 25.00 | &nbsp;&nbsp; -75.00% | &nbsp;&nbsp; $4.500 | &nbsp;&nbsp; -55.00% |
| &nbsp;&nbsp; 50.00 | &nbsp;&nbsp; -50.00% | &nbsp;&nbsp; $7.000 | &nbsp;&nbsp; -30.00% |
| &nbsp;&nbsp; 60.00 | &nbsp;&nbsp; -40.00% | &nbsp;&nbsp; $8.000 | &nbsp;&nbsp; -20.00% |
| &nbsp;&nbsp; 70.00 | &nbsp;&nbsp; -30.00% | &nbsp;&nbsp; $9.000 | &nbsp;&nbsp; -10.00% |
| &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;80.00<sup>(2)</sup> | &nbsp;&nbsp; -20.00% | &nbsp;&nbsp; $10.000 | &nbsp;&nbsp; 0.00% |
| &nbsp;&nbsp; 90.00 | &nbsp;&nbsp; -10.00% | &nbsp;&nbsp; $10.000 | &nbsp;&nbsp; 0.00% |
| &nbsp;&nbsp; 95.00 | &nbsp;&nbsp; -5.00% | &nbsp;&nbsp; $10.000 | &nbsp;&nbsp; 0.00% |
| &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;100.00<sup>(3)</sup> | &nbsp;&nbsp; 0.00% | &nbsp;&nbsp; $10.000 | &nbsp;&nbsp; 0.00% |
| &nbsp;&nbsp; 105.00 | &nbsp;&nbsp; 5.00% | &nbsp;&nbsp; $11.213 | &nbsp;&nbsp; 12.13% |
| &nbsp;&nbsp; 110.00 | &nbsp;&nbsp; 10.00% | &nbsp;&nbsp; $12.425 | &nbsp;&nbsp; 24.25% |
| &nbsp;&nbsp; 120.00 | &nbsp;&nbsp; 20.00% | &nbsp;&nbsp; $14.850 | &nbsp;&nbsp; 48.50% |
| &nbsp;&nbsp; 130.00 | &nbsp;&nbsp; 30.00% | &nbsp;&nbsp; $17.275 | &nbsp;&nbsp; 72.75% |
| &nbsp;&nbsp; 140.00 | &nbsp;&nbsp; 40.00% | &nbsp;&nbsp; $19.700 | &nbsp;&nbsp; 97.00% |
| &nbsp;&nbsp; 150.00 | &nbsp;&nbsp; 50.00% | &nbsp;&nbsp; $22.125 | &nbsp;&nbsp; 121.25% |

---

<sup>(1)</sup> The Redemption Amount per unit is based on the hypothetical Participation Rate.

<sup>(2)</sup> This is the hypothetical Threshold Value of the Worst-Performing Market Measure.

<sup>(3)</sup> The **hypothetical** Starting Value of 100.00 used in these examples has been chosen for illustrative purposes only, and does not represent a likely actual Starting Value for any Index.

<br> Leveraged Index Return Notes<sup>®</sup> TS-5

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

**Redemption Amount Calculation Examples**

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Example 1** | &nbsp;&nbsp; **Example 1** |
| &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 60.00, or 60.00% of its Starting Value: | &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 60.00, or 60.00% of its Starting Value: |
| &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure : 100.00 | &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure : 100.00 |
| &nbsp;&nbsp; Threshold Value of the Worst-Performing Market Measure : 80.00 | &nbsp;&nbsp; Threshold Value of the Worst-Performing Market Measure : 80.00 |
| &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure : 60.00 | &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure : 60.00 |
| &nbsp;&nbsp; ![](image6.gif)  | &nbsp;&nbsp; **= $8.00** Redemption Amount per unit |
| &nbsp;&nbsp; **Example 2** | &nbsp;&nbsp; **Example 2** |
| &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 90.00, or 90.00% of its Starting Value: | &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 90.00, or 90.00% of its Starting Value: |
| &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure: 100.00 | &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure: 100.00 |
| &nbsp;&nbsp; Threshold Value of the Worst-Performing Market Measure: 80.00 | &nbsp;&nbsp; Threshold Value of the Worst-Performing Market Measure: 80.00 |
| &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure: 90.00 | &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure: 90.00 |
| &nbsp;&nbsp; Redemption Amount per unit **= $10.00**, the principal amount, since the Ending Value of the Worst-Performing Market Measure is less than its Starting Value but equal to or greater than its Threshold Value | &nbsp;&nbsp; Redemption Amount per unit **= $10.00**, the principal amount, since the Ending Value of the Worst-Performing Market Measure is less than its Starting Value but equal to or greater than its Threshold Value |
| &nbsp;&nbsp; **Example 3** | &nbsp;&nbsp; **Example 3** |
| &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 110.00, or 110.00% of its Starting Value: | &nbsp;&nbsp; The Ending Value of the Worst-Performing Market Measure is 110.00, or 110.00% of its Starting Value: |
| &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure: 100.00 | &nbsp;&nbsp; Starting Value of the Worst-Performing Market Measure: 100.00 |
| &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure: 110.00 | &nbsp;&nbsp; Ending Value of the Worst-Performing Market Measure: 110.00 |
| &nbsp;&nbsp; ![](image7.gif)  | &nbsp;&nbsp; **= $12.425** Redemption Amount per unit |

---

<br> Leveraged Index Return Notes<sup>®</sup> TS-6

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Risk Factors

*There are important differences between the notes and a conventional debt security. An investment in the notes involves significant risks, including those listed below. You should carefully review the more detailed explanation of risks relating to the notes in the "Risk Factors" sections beginning on page PS-6 of the accompanying product supplement, page S-2 of the prospectus supplement and Annex A of the prospectus addendum identified above. The notes are not an appropriate investment for you if you are not knowledgeable about significant elements of the notes or financial matters in general. We also urge you to consult your investment, legal, tax, accounting, and other advisors before you invest in the notes.* 

**<u>Structure-related Risks</u>**

￭Your investment in the notes may result in a loss. There is no fixed principal repayment amount on the notes at maturity. If the Ending Value of the Worst-Performing Market Measure is less than its Threshold Value, you will receive a Redemption Amount at maturity that will be less than, and possibly significantly less than, the principal amount of your notes.

￭Payments on the notes will not reflect changes in the value of the Indices other than on the Final Calculation Day. As a result, even if the level of the Indices increase during the term of the notes, you will receive a Redemption Amount that is less than the principal amount if the Ending Value of the Worst-Performing Market Measure is less than its Threshold Value on the Final Calculation Day, even if the level of the Worst-Performing Market Measure was always greater than its Threshold Value prior to the Final Calculation Day.

￭The notes are subject to the risks of each Index, not a basket composed of the Indices, and will be negatively affected if the level of either Index decreases below its Threshold Value on the Final Calculation Day, even if the level of the other Index is above its Threshold Value as of that day.

￭You will not benefit in any way from the performance of the better performing Index.

￭Because the notes are linked to multiple Indices, as opposed to only one, it is more likely that the Ending Value of any Index will be less than its Threshold Value on the Final Calculation Day, and consequently, you will not receive a positive return on the notes and will lose some or all of your investment.

￭You will be subject to risks relating to the relationship between the Indices. The less correlated the Indices, the more likely it is that the Ending Value of one of the Indices will be below its Threshold Value on the Final Calculation Day.

￭Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity.

￭Payments on the notes are subject to the credit risk of JPMorgan Financial, as issuer, and the credit risk of JPMorgan Chase & Co., as guarantor, and any actual or perceived changes in our or JPMorgan Chase & Co.'s creditworthiness are expected to affect the value of the notes. If we and JPMorgan Chase & Co. become insolvent or are unable to pay our respective obligations, you may lose your entire investment.

￭As a finance subsidiary of JPMorgan Chase & Co., we have no independent operations beyond the issuance and administration of our securities and the collection of intercompany obligations. Aside from the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of JPMorgan Chase & Co. to make payments under loans made by us to JPMorgan Chase & Co. or under other intercompany agreements. As a result, we are dependent upon payments from JPMorgan Chase & Co. to meet our obligations under the notes. We are not a key operating subsidiary of JPMorgan Chase & Co. and in a bankruptcy or resolution of JPMorgan Chase & Co. we are not expected to have sufficient resources to meet our obligations in respect of the notes as they come due. If JPMorgan Chase & Co. does not make payments to us and we are unable to make payments on the notes, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co. For more information, see the accompanying prospectus addendum.

**<u>Valuation- and Market-related Risks</u>**

￭The estimated value of the notes is only an estimate determined by reference to several factors. The original issue price of the notes will exceed the estimated value of the notes because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These costs include the selling commissions, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. See "The Estimated Value of the Notes" in this term sheet.

￭The estimated value of the notes is determined by reference to internal pricing models of our affiliates when the terms of the notes are set. This estimated value of the notes is based on market conditions and other relevant factors existing at that time and assumptions about market parameters, which can include volatility, dividend rates, interest rates and other factors. Different pricing models and assumptions could provide valuations for the notes that are greater than or less than the estimated value of the notes. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the notes could change significantly based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.'s creditworthiness, interest rate movements and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy notes from you in secondary market transactions. See "The Estimated Value of the Notes" in this term sheet.

￭The internal funding rate used in the determination of the estimated value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any

<br> Leveraged Index Return Notes<sup>®</sup> TS-7

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

difference may be based on, among other things, our and our affiliates' view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the notes and any secondary market prices of the notes. See "The Estimated Value of the Notes" in this term sheet.

￭We generally expect that some of the costs included in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial predetermined period. These costs can include projected hedging profits, if any, and, in some circumstances, estimated hedging costs and our internal secondary market funding rates for structured debt issuances. Accordingly, the estimated value of your notes during this initial period may be lower than the value of the notes as published by JPMS (and which may be shown on your customer account statements).

￭Any secondary market prices of the notes will likely be lower than the original issue price of the notes because, among other things, secondary market prices take into account our internal secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions, projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the notes. As a result, the price, if any, at which JPMS will be willing to buy notes from you in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the maturity date could result in a substantial loss to you. See the immediately following risk consideration for information about additional factors that will impact any secondary market prices of the notes.

The notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your notes to maturity.

￭The secondary market price of the notes during their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the selling commissions, projected hedging profits, if any, estimated hedging costs and the level of the Indices.

Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may be willing to purchase your notes in the secondary market. See "Risk Factors — Valuation- and Market-related Risks — The notes are not designed to be short-term trading instruments, and if you attempt to sell the notes prior to maturity, their market value, if any, will be affected by various factors that interrelate in complex ways, and their market value may be less than the principal amount" in the accompanying product supplement.

￭A trading market is not expected to develop for the notes. None of us, JPMorgan Chase & Co., JPMS or MLPF&S is obligated to make a market for, or to repurchase, the notes. There is no assurance that any party will be willing to purchase your notes at any price in any secondary market.

**<u>Conflict-related Risks</u>**

￭Our hedging and trading activities (including trades in shares of companies included in the Indices) and any hedging and trading activities we, JPMorgan Chase & Co., JPMS or MLPF&S or our other or their affiliates engage in that are not for your account or on your behalf, may affect the market value and return of the notes and may create conflicts of interest with you.

￭There may be potential conflicts of interest involving the calculation agent, which is an affiliate of ours. We have the right to appoint and remove the calculation agent.

**<u>Market Measure-related Risks</u>**

￭A Market Measure sponsor may adjust its applicable Index in a way that affects its level, and has no obligation to consider your interests.

￭You will not have any rights with respect to either Index or its underlying securities, including any voting rights or any right to receive dividends or other distributions.

￭While we, JPMorgan Chase & Co., JPMS, MLPF&S and our other or their affiliates may from time to time own securities of companies included in the Indices, except to the extent that JPMorgan Chase & Co.'s common stock is included in either Index, we, JPMorgan Chase & Co., JPMS, MLPF&S and our other or their affiliates do not control any company included in either Index, and have not verified any disclosure made by any other company. You should undertake your own investigation into the Indices and their underlying assets.

**<u>Tax-related Risks</u>**

￭The U.S. federal income tax consequences of the notes are uncertain and may be adverse to a holder of the notes. See "Summary Tax Consequences" below and "Material U.S. Federal Income Tax Consequences" beginning on page PS-61 of the accompanying product supplement.

<br> Leveraged Index Return Notes<sup>®</sup> TS-8

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Additional Risk Factors

**<u>Non-U.S Securities</u> <u>Risk</u>**

￭The equity securities included in the Market Measures have been issued by non-U.S. companies. Investments in securities linked to the value of such non-U.S. equity securities involve risks associated with the securities markets in the home countries of the issuers of those non-U.S. equity securities, including risks of volatility in those markets, governmental intervention in those markets and cross shareholdings in companies in certain countries. Also, there is generally less publicly available information about companies in some of these jurisdictions than there is about U.S. companies that are subject to the reporting requirements of the SEC.

**<u>No Direct Exposure To Fluctuations In Foreign Exchange Rates</u>**

￭The value of your notes will not be adjusted for exchange rate fluctuations between the U.S. dollar and the currencies upon which the equity securities included in the Market Measures are based, although any currency fluctuations could affect the performance of the Market Measures . Therefore, if the applicable currencies appreciate or depreciate relative to the U.S. dollar over the term of the notes, you will not receive any additional payment or incur any reduction in any payment on the notes.

Other Terms of the Notes

**Market Measure Business Day**

The provisions of this section supersede and replace the definition of "Market Measure Business Day" set forth in the accompanying product supplement.

**Market Measure Business Day**

A "Market Measure Business Day" means a day on which:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) each of the Eurex (as to the EURO STOXX 50<sup>®</sup> Index) and the SIX Swiss Exchange (as to the Swiss Market Index (or any successor to the foregoing exchanges) are open for trading; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the Market Measures or any successors thereto are calculated and published.

<br> Leveraged Index Return Notes<sup>®</sup> TS-9

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

The Indices

The EURO STOXX 50<sup>®</sup> Index is a free-float market capitalization weighted index composed of 50 of the largest stocks in terms of free-float market capitalization traded on the major exchanges of 11 Eurozone countries.

The Swiss Market Index is a free float-adjusted market capitalization-weighted price return index of the Swiss equity market. The SMI<sup>®</sup> was standardized on June 30, 1988 with an initial baseline value of 1,500 points

For additional information about the Indices, see Annex A of this term sheet.

***The following graphs show the daily historical performance of the Indices in the period from January 4, 2016 through February 27, 2026. We obtained this historical data from Bloomberg L.P. We have not independently verified the accuracy or completeness of the information obtained from Bloomberg L.P. On February 27, 2026 the closing level of the EURO STOXX 50***<sup>®</sup> ***Index was 6,138.41. On February 27, 2026 the closing level of the Swiss Market Index was 14,014.30.***

**Historical Performance of the EURO STOXX 50**<sup>®</sup> **Index**

**Historical Performance of the Swiss Market Index**

![](image9.gif)

***This historical data on the Indices is not necessarily indicative of the future performance of the Indices or what the value of the notes may be. Any historical upward or downward trend in the levels of the Indices during any period set forth above is not an indication that the levels of the Indices are more or less likely to increase or decrease at any time over the term of the notes.***

Before investing in the notes, you should consult publicly available sources for the levels of the Indices.

<br> Leveraged Index Return Notes<sup>®</sup> TS-10

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Supplement to the Plan of Distribution; Conflicts of Interest

See "Plan of Distribution (Conflicts of Interest)" on page PS-59 of the accompanying product supplement.

JPMS will purchase the notes from us as principal at the public offering price indicated on the cover of this term sheet, less the indicated underwriting discount. MLPF&S will purchase the notes from JPMS for resale and will receive a selling concession in connection with the sale of the notes in an amount up to the full amount of underwriting discount set forth on the cover of this term sheet. MLPF&S will offer the notes at the public offering price set forth on the cover page hereto.

We will pay a fee to LFT Securities, LLC for providing certain electronic platform services with respect to this offering, which will reduce the economic terms of the notes to you. An affiliate of MLPF&S has an ownership interest in LFT Securities, LLC.

JPMS has a "conflict of interest" within the meaning of FINRA Rule 5121 in any offering of the notes in which it participates because JPMorgan Chase & Co. owns, directly or indirectly, all of the outstanding equity securities of JPMS, because JPMS and JPMorgan Financial are under common control by JPMorgan Chase & Co. and because the net proceeds received from the sale of the notes will be used, in part, by JPMS or its affiliates in connection with hedging the Issuer's obligations under the notes. The offer and sale of the notes by JPMS will comply with the requirements of FINRA Rule 5121 regarding a FINRA member firm's participation in a public offering of notes of an affiliate. In accordance with FINRA Rule 5121, neither JPMS nor any other affiliated underwriter, agent or dealer of the Issuer may sell the notes to any of its discretionary accounts without the specific written approval of the customer.

We may deliver the notes against payment therefor in New York, New York on a date that is greater than one business day following the pricing date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, if the initial settlement of the notes occurs more than one business day from the pricing date, purchasers who wish to trade the notes more than one business day prior to the original issue date will be required to specify alternative settlement arrangements to prevent a failed settlement.

The notes will not be listed on any securities exchange. In the original offering of the notes, the notes will be sold in minimum investment amounts of 10,000 units. If you place an order to purchase the notes, you are consenting to MLPF&S and/or one of its affiliates acting as a principal in effecting the transaction for your account.

For information about factors that will impact any secondary market prices of the notes, see "Risk Factors — Valuation- and Market-related Risks — The notes are not designed to be short-term trading instruments, and if you attempt to sell the notes prior to maturity, their market value, if any, will be affected by various factors that interrelate in complex ways, and their market value may be less than the principal amount." in the accompanying product supplement. In addition, we generally expect that some of the costs included in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial predetermined period. These costs can include projected hedging profits, if any, and, in some circumstances, estimated hedging costs and our internal secondary market funding rates for structured debt issuances. This initial predetermined time period is intended to be the shorter of six months and one-half of the stated term of the notes. The length of any such initial period reflects the structure of the notes, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs of hedging the notes and when these costs are incurred, as determined by our affiliates.

The value of the notes shown on your account statement will be based on JPMS' estimate of the value of the notes if JPMS were to make a market in the notes, which it is not obligated to do. That estimate will be based upon the price that JPMS may pay for the notes in light of then-prevailing market conditions and other considerations, as mentioned above, and will include transaction costs. At certain times, this price may be higher than or lower than the initial estimated value of the notes. Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may be willing to purchase your notes in any secondary market.

<br> Leveraged Index Return Notes<sup>®</sup> TS-11

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Supplemental Use of Proceeds

The notes are offered to meet investor demand for products that reflect the risk-return profile and market exposure provided by the notes. See "Examples of Hypothetical Payments" in this term sheet for an illustration of the risk-return profile of the notes.

The original issue price of the notes is equal to the estimated value of the notes plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes, plus the estimated cost of hedging our obligations under the notes.

Any secondary market prices of the notes will likely be lower than the original issue price of the notes because, among other things, secondary market prices take into account the Issuer's internal secondary market funding rates for structured debt issuances, and, also, because secondary market prices (a) exclude referral fees, if any, and structuring fees, if any, and (b) may exclude selling commissions, projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the notes. As a result, the price, if any, at which JPMS will be willing to buy notes from you in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the maturity date could result in a substantial loss to you. See "Risk Factors — Valuation- and Market-related Risks — Secondary trading may be limited." in the accompanying product supplement for additional information about additional factors that will impact any secondary market prices of the notes.

The Estimated Value of the Notes

The estimated value of the notes set forth on the cover of this term sheet is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the notes. The estimated value of the notes does not represent a minimum price at which JPMS would be willing to buy your notes in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates' view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the notes and any secondary market prices of the notes. For additional information, see "Valuation- and Market-related Risks" in this term sheet. The value of the derivative or derivatives underlying the economic terms of the notes is derived from internal pricing models of our affiliates. These models are dependent on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments. Accordingly, the estimated value of the notes is determined when the terms of the notes are set based on market conditions and other relevant factors and assumptions existing at that time. See "Valuation- and Market-related Risks" in this term sheet.

The estimated value of the notes will be lower than the original issue price of the notes because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. Because hedging our obligations entails risk and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. We or one or more of our affiliates will retain any profits realized in hedging our obligations under the notes. See "Valuation- and Market-related Risks" in this term sheet.

<br> Leveraged Index Return Notes<sup>®</sup> TS-12

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Summary Tax Consequences

You should review carefully the section entitled "Material U.S. Federal Income Tax Consequences" in the accompanying product supplement no. EQUITY MLI-1. The following discussion, when read in combination with that section, constitutes the full opinion of our special tax counsel, Latham & Watkins LLP, regarding the material U.S. federal income tax consequences of owning and disposing of notes.

Based on current market conditions, in the opinion of our special tax counsel it is reasonable to treat the notes as "open transactions" that are not debt instruments for U.S. federal income tax purposes, as more fully described in "Material U.S. Federal Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Open Transactions That Are Not Debt Instruments" in the accompanying product supplement. Assuming this treatment is respected, the gain or loss on your notes should be treated as long-term capital gain or loss if you hold your notes for more than a year, whether or not you are an initial purchaser of notes at the issue price. However, the IRS or a court may not respect this treatment, in which case the timing and character of any income or loss on the notes could be materially and adversely affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of "prepaid forward contracts" and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the "constructive ownership" regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the notes, possibly with retroactive effect. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes, including possible alternative treatments and the issues presented by this notice.

Withholding under legislation commonly referred to as "FATCA" may (if the notes are recharacterized as debt instruments) apply to amounts treated as interest paid with respect to the notes, as well as to payments of gross proceeds of a taxable disposition, including redemption at maturity, of a note, although under recently proposed regulations (the preamble to which specifies that taxpayers are permitted to rely on them pending finalization), no withholding will apply to payments of gross proceeds (other than any amount treated as interest). You should consult your tax adviser regarding the potential application of FATCA to the notes.

<br> Leveraged Index Return Notes<sup>®</sup> TS-13

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Where You Can Find More Information

We and JPMorgan Chase & Co. have filed a registration statement (including a product supplement, a prospectus supplement, and a prospectus) with the SEC for the offering to which this term sheet relates. Before you invest, you should read the Note Prospectus, including this term sheet, and the other documents relating to this offering that we and JPMorgan Chase & Co. have filed with the SEC, for more complete information about us, JPMorgan Chase & Co. and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at <u>www.sec.gov</u> or by calling MLPF&S toll-free at 1-800-294-1322.

**You may revoke your offer to purchase the notes at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of, or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.**

You should read this term sheet together with the accompanying prospectus, as supplemented by the accompanying prospectus supplement relating to our Series A medium-term notes of which these notes are a part, the accompanying prospectus addendum and the more detailed information contained in the accompanying product supplement. **This term sheet, together with the documents listed on page TS-4 of this term sheet, contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours.** You should carefully consider, among other things, the matters set forth in the "Risk Factors" sections of the accompanying prospectus supplement and the accompanying product supplement and in Annex A to the accompanying prospectus addendum, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the notes.

Our Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase & Co.'s CIK is 19617. As used in this term sheet, "we," "us" and "our" refer to JPMorgan Financial.

<br> Leveraged Index Return Notes<sup>®</sup> TS-14

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

Annex A:

**The EURO STOXX 50**<sup>®</sup> **Index**

The EURO STOXX 50<sup>®</sup> Index is a free-float market capitalization weighted index composed of 50 of the largest stocks in terms of free-float market capitalization traded on the major exchanges of 11 Eurozone countries: Austria, Belgium, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain. At any given time, some eligible countries may not be represented in the EURO STOXX 50<sup>®</sup> Index. The euro price return version of the EURO STOXX 50<sup>®</sup> Index is reported by Bloomberg L.P. under the ticker symbol "SX5E."

The selection list for the EURO STOXX<sup>®</sup> 50 Index is composed of the components of the EURO STOXX<sup>®</sup> Index. In addition, the selection list for the EURO STOXX<sup>®</sup> 50 Index includes the top 60% of the free-float market capitalization of each of the 20 EURO STOXX<sup>®</sup> Supersector indices and all current EURO STOXX<sup>®</sup> 50 Index component stocks. All the stocks on the selection list are ranked in terms of free-float market capitalization. The largest 40 stocks on the selection list are selected for inclusion in the EURO STOXX<sup>®</sup> 50 Index; the remaining 10 stocks are selected from the largest remaining current stocks ranked between 41 and 60. If the number of stocks selected is still below 50, then the largest remaining stocks are selected until there are 50 stocks.

The weighting cap factor limits the weight of each component stock within the EURO STOXX<sup>®</sup> 50 Index to a maximum of 10% of the EURO STOXX<sup>®</sup> 50 Index at the time of each review.

**STOXX Benchmark Index Maintenance**

The composition of each of the EURO STOXX<sup>®</sup> Index and the EURO STOXX<sup>®</sup> Supersector Indices is reviewed quarterly in March, June, September and December. The review cut off date is the last trading day of the month preceding the review month.

The composition of the EURO STOXX 50<sup>®</sup> Index is reviewed annually in September. The review cut-off date is the last trading day of August. The composition of the EURO STOXX 50<sup>®</sup> Index is also reviewed monthly and components that rank 75 or below are replaced and non-component stocks that rank 25 or above are added.

In addition, changes to country classification and listing are effective as of the next quarterly review. At that time, the relevant STOXX Benchmark Index is adjusted accordingly to remain consistent with its country membership rules by deleting the company where necessary.

The STOXX Benchmark Indices are also reviewed on an ongoing basis. Corporate actions (including initial public offerings, mergers and takeovers, spin-offs, delistings, bankruptcy, and price and share adjustments) that affect a STOXX Benchmark Index composition are immediately reviewed. Any changes are announced, implemented and effective in line with the type of corporate action and the magnitude of the effect.

With respect to the STOXX Benchmark Indices, to maintain the number of components constant, a removed company is replaced by the highest-ranked non-component on the relevant selection list. The selection list is updated on a monthly basis according to the review component selection process.

The free-float factors for each component stock used to calculate each STOXX Benchmark Index are reviewed, calculated and implemented on a quarterly basis and are fixed until the next quarterly review.

**STOXX Benchmark Index Calculation**

Each STOXX Benchmark Index is calculated with the "Laspeyres formula," which measures the aggregate price changes in the component stocks against a fixed base quantity weight. The formula for calculating the value of a STOXX Benchmark Index can be expressed as follows:

![](image10.gif)

The "free-float market capitalization of the relevant STOXX Benchmark Index" is equal to the sum of the products, for each component stock, of the price, number of shares, free-float factor, weighting cap factor and, if applicable, the exchange rate from the local currency into the index currency of the relevant STOXX Benchmark Index as of the time that STOXX Benchmark Index is being calculated.

The free-float factor of each component stock is intended to reduce the number of shares to the actual amount available on the market. All fractions of the total number of shares that are larger than or equal to 5% and whose holding is of a long-term nature are excluded from the calculation of the STOXX Benchmark Indices, including: cross-ownership (stock owned either by the company itself, in the form of treasury shares, or owned by other companies); government ownership (stock owned by either governments or their agencies); private ownership (stock owned by either individuals or families); and restricted shares that cannot be traded during a certain period or have a foreign ownership restriction. Block ownership is not applied for holdings of custodian nominees, trustee companies, mutual funds, investment companies with short-term investment strategies, pension funds and similar entities.

Each STOXX Benchmark Index is also subject to a divisor, which is adjusted to maintain the continuity of the values of that STOXX Benchmark Index despite changes due to corporate actions. The following is a summary of the adjustments to any component stock of a STOXX Benchmark Index made for corporate actions and the effect of such adjustment on the divisor of that STOXX Benchmark Index, where shareholders of the component stock will receive "B" number of shares for every "A" share held (where applicable).

<br> Buffered Index Return Notes A-1

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| &nbsp;&nbsp; (1) *Special cash dividend:*<br> Cash distributions that are outside the scope of the regular dividend policy or that the company defines as an extraordinary distribution<br> Adjusted price = closing price – dividend announced by the company × (1 – withholding tax if applicable)<br> Divisor: decreases | &nbsp;&nbsp; (1) *Special cash dividend:*<br> Cash distributions that are outside the scope of the regular dividend policy or that the company defines as an extraordinary distribution<br> Adjusted price = closing price – dividend announced by the company × (1 – withholding tax if applicable)<br> Divisor: decreases |
| &nbsp;&nbsp; (2) *Split and reverse split:*<br> Adjusted price = closing price × A / B<br> New number of shares = old number of shares × B / A<br> Divisor: unchanged | &nbsp;&nbsp; (2) *Split and reverse split:*<br> Adjusted price = closing price × A / B<br> New number of shares = old number of shares × B / A<br> Divisor: unchanged |
| &nbsp;&nbsp; (3) *Rights offering:*<br> If the subscription price is not available or if the subscription price is equal to or greater than the closing price on the day before the effective date, then no adjustment is made.<br> If the subscription price is available as a price range and not as a fixed price, the price and share adjustment is performed only if both lower and upper range are in the money. The average value between lower and upper range will be used as a subscription price.<br> In case the share increase is greater than or equal to 100% (B / A ≥ 1), the adjustment of the shares and weight factors are delayed until the new shares are listed.<br> Adjusted price = (closing price × A + subscription price × B) / (A + B)<br> New number of shares = old number of shares × (A + B) / A<br> Divisor: increases | &nbsp;&nbsp; (3) *Rights offering:*<br> If the subscription price is not available or if the subscription price is equal to or greater than the closing price on the day before the effective date, then no adjustment is made.<br> If the subscription price is available as a price range and not as a fixed price, the price and share adjustment is performed only if both lower and upper range are in the money. The average value between lower and upper range will be used as a subscription price.<br> In case the share increase is greater than or equal to 100% (B / A ≥ 1), the adjustment of the shares and weight factors are delayed until the new shares are listed.<br> Adjusted price = (closing price × A + subscription price × B) / (A + B)<br> New number of shares = old number of shares × (A + B) / A<br> Divisor: increases |
| &nbsp;&nbsp; (4) *Stock dividend:*<br> Adjusted price = closing price × A / (A + B)<br> New number of shares = old number of<br>shares × (A + B) / A<br> Divisor: unchanged | &nbsp;&nbsp; (5) *Stock dividend (from treasury stock):*<br> Adjusted only if treated as extraordinary dividend.<br> Adjusted close = close - close × B / (A + B)<br> Divisor: decreases |
| &nbsp;&nbsp; (6) *Stock dividend (from redeemable shares):*<br> Adjusted only if treated as extraordinary dividend.<br> Adjusted close = close – close × B / (A + B)<br> Divisor: decreases | &nbsp;&nbsp; (7) *Stock dividend of another company:*<br> Adjusted price = (closing price × A - price of other company × B) / A<br> Divisor: decreases |
| &nbsp;&nbsp; (8) *Return of capital and share consolidation:*<br> Adjusted price = (closing price – capital return announced by company × (1-withholding tax)) × A / B<br> New number of shares = old number of shares × B / A<br> Divisor: decreases | &nbsp;&nbsp; (9) *Repurchase of shares / self-tender:*<br> Adjusted price = ((price before tender × old number of shares) – (tender price × number of tendered shares)) / (old number of shares – number of tendered shares)<br> New number of shares = old number of shares – number of tendered shares<br> Divisor: decreases |
| &nbsp;&nbsp; (10) *Spin–off:*<br> Adjusted price = (closing price × A – price of spun–off shares × B) / A<br> Divisor: decreases | &nbsp;&nbsp; (10) *Spin–off:*<br> Adjusted price = (closing price × A – price of spun–off shares × B) / A<br> Divisor: decreases |
| &nbsp;&nbsp; (11) *Combination stock distribution (dividend or split) and rights offering:*<br> For this corporate action, the following additional assumptions apply:<br> Shareholders receive B new shares from the distribution and C new shares from the rights offering for every A share held.<br> If A is not equal to one share, all the following "**new number of shares**" formulae need to be divided by A: | &nbsp;&nbsp; (11) *Combination stock distribution (dividend or split) and rights offering:*<br> For this corporate action, the following additional assumptions apply:<br> Shareholders receive B new shares from the distribution and C new shares from the rights offering for every A share held.<br> If A is not equal to one share, all the following "**new number of shares**" formulae need to be divided by A: |

---

<br> Buffered Index Return Notes A-2

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

---

| | |
|:---|:---|
| &nbsp;&nbsp; *– If rights are applicable after stock distribution (one action applicable to other):*<br> Adjusted price = (closing price × A + subscription price × C × (1 + B / A)) / ((A + B) × (1 + C / A))<br> New number of shares = old number of shares × | &nbsp;&nbsp; *– If stock distribution is applicable after rights (one action applicable to other):*<br> Adjusted price = (closing price × A + subscription price × C) /((A + C) × (1 + B / A))<br> New number of shares = old number of shares × |
| &nbsp;&nbsp; ((A + B) × (1 + C / A)) / A<br> Divisor: increases | &nbsp;&nbsp; ((A + C) × (1 + B / A))<br> Divisor: increases |
| &nbsp;&nbsp; *– Stock distribution and rights (neither action is applicable to the other):*<br> Adjusted price = (closing price × A + subscription price × C) / (A + B + C)<br> New number of shares = old number of shares × (A + B + C) / A<br> Divisor: increases | &nbsp;&nbsp; *– Stock distribution and rights (neither action is applicable to the other):*<br> Adjusted price = (closing price × A + subscription price × C) / (A + B + C)<br> New number of shares = old number of shares × (A + B + C) / A<br> Divisor: increases |
| &nbsp;&nbsp; (12) *Addition / deletion of a company:*<br> No price adjustments are made. The net change in market capitalization determines the divisor adjustment. | &nbsp;&nbsp; (13) *Free-float and shares changes:*<br> No price adjustments are made. The net change in market capitalization determines the divisor adjustment. |

---

**License Agreement**

JPMorgan Chase & Co. or its affiliate has entered into an agreement with STOXX Limited ("**STOXX**") providing it and certain of its affiliates or subsidiaries, including JPMorgan Financial, with a non-exclusive license and, for a fee, with the right to use each STOXX Benchmark Index, which is owned and published by STOXX Limited, in connection with certain securities, including the notes.

STOXX and its licensors (the "**Licensors**") have no relationship to the Issuer or the Guarantor (if applicable), other than the licensing of any STOXX Benchmark Index and the related trademarks for use in connection with the notes.

**STOXX and its Licensors do <u>not</u>:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•sponsor, endorse, sell or promote the notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•recommend that any person invest in the notes or any other securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•have any responsibility or liability for or make any decisions about the timing, amount or pricing of the notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•have any responsibility or liability for the administration, management or marketing of the notes; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•consider the needs of the notes or the holders of the notes in determining, composing or calculating any STOXX Benchmark Index or have any obligation to do so.

**STOXX and its Licensors will not have any liability in connection with the notes. Specifically,**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•STOXX and its Licensors do not make any warranty, express or implied and disclaim any and all warranty about:

oThe results to be obtained by the notes, the holders of the notes or any other person in connection with the use of any STOXX Benchmark Index and the data included in any STOXX Benchmark Index;

oThe accuracy or completeness of any STOXX Benchmark Index and its data; or

oThe merchantability and the fitness for a particular purpose or use of any STOXX Benchmark Index and its data;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•STOXX and its Licensors will have no liability for any errors, omissions or interruptions in any STOXX Benchmark Index or its data; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Under no circumstances will STOXX or its Licensors be liable for any lost profits or indirect, punitive, special or consequential damages or losses, even if STOXX or its Licensors knows that they might occur.

**The licensing agreement with STOXX is solely for the benefit of the parties to that agreement and not for the benefit of the holders of the notes or any other third parties.**

**The Swiss Market Index (the "SMI**<sup>®</sup>**")**

The SMI<sup>®</sup> is a free float-adjusted market capitalization-weighted price return index of the Swiss equity market. The SMI<sup>®</sup> was standardized on June 30, 1988 with an initial baseline value of 1,500 points.

**Composition of the SMI**<sup>®</sup>

The SMI<sup>®</sup> is composed of the most highly capitalized and liquid stocks of the Swiss Performance Index ("**SPI**<sup>®</sup>"). The SMI<sup>®</sup> represents more than 75% of the free-float market capitalization of the Swiss equity market.

<br> Buffered Index Return Notes A-3

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

The SMI<sup>®</sup> is composed of the 20 highest ranked securities of the SPI<sup>®</sup>, where the ranking of each security is determined by a combination of the following criteria:

· average free-float
market capitalization over the last 12 months (compared to the capitalization of the entire SPI <sup>®</sup>);
and

· cumulated on
order book turnover over the last 12 months (compared to the total turnover of the SPI <sup>®</sup>).

The average market capitalization in percent and the turnover in percent are each given a weighting of 50% and yield the weighted market share. A security is excluded from the SMI<sup>®</sup> if it ranked 23 or lower in the selection list. To reduce fluctuations in the SMI<sup>®</sup>, a buffer is applied for securities ranked 19 to 22. Out of the candidates from ranks 19 to 22, current components are selected with priority over the other candidates. New components out of the buffer are selected until 20 components have been reached. Instruments that are primary listed on more than one stock exchange and generate less than 50% of their total turnover at SIX Swiss Exchange, need to fulfill additional liquidity criteria in order to be selectable for the SMI<sup>®</sup>. For this purpose, all components of the SPI<sup>®</sup> are ranked based on their cumulated order book turnover over the past 12 months relative to the total turnover of the index universe. For this list, only turnovers of stock exchanges are considered where the instrument is primary listed. Such an instrument with several primary listings must rank among the first 18 components on the order book turnover list in order to be selectable for the SMI<sup>®</sup>. Such an instrument is excluded from the SMI<sup>®</sup> once it reaches 23 or lower.

**Standards for Admission and Exclusion**

To ensure that the composition of the SMI<sup>®</sup> maintains a high level of continuity, the stocks contained within it are subject to a special admission and exclusion procedure. This is based on the criteria of free-float market capitalization and liquidity. The index-basket adjustments which arise from this procedure are, as a rule, made once per year.

The securities included in the SMI<sup>®</sup> are weighted according to their free float. The free float is calculated only for shares with voting rights. This means that large positions in a security that reach or exceed the threshold of 5% and are held in firm hands are subtracted from the total market capitalization. The following positions in a security are deemed to be held in firm hands:

· Shareholding
that has been acquired by one person or a group of persons who are subject to a shareholder or lockup agreement.

· Shareholding
that has been acquired by one person or a group of persons who according to publicly known facts, have a long-term interest in a company.

The positions in a security held by institutions of the following kind are deemed free floating:

&nbsp;&nbsp;&nbsp;&nbsp;· custodian nominees

&nbsp;&nbsp;&nbsp;&nbsp;· trustee companies

&nbsp;&nbsp;&nbsp;&nbsp;· investment funds

&nbsp;&nbsp;&nbsp;&nbsp;· pension funds

&nbsp;&nbsp;&nbsp;&nbsp;· investment companies

The SIX Swiss Exchange classifies at its own discretion persons and groups of persons who, because of their area of activity or the absence of important information, cannot be clearly assigned.

*Ordinary Index Review*

Each year on the third Friday of September, the composition of the SMI<sup>®</sup> is updated in the ordinary index review based on the selection list of June. With the cut-off dates on March 31, September 30 and December 31, a provisional selection list is created, which serves as the basis for the adjustment of extraordinary corporate actions. The number of securities and free-float shares are adjusted on four ordinary adjustment dates a year: the third Friday in March, June, September and December.

*Extraordinary Corporate Actions*

An extraordinary corporate action is an initial public offering ("**IPO**"), merger and acquisition activity, spin-off, insolvency or any other event that leads to a listing or delisting. An extraordinary corporate action has an ex-date, but its effect can usually not be calculated by a generic predefined formula. In most cases, an extraordinary corporate action leads to a new listing or delisting and subsequently there is a change in the composition of the SMI<sup>®</sup> and in the component weights of the composition of the SMI<sup>®</sup>.

Newly listed instruments that fulfill the selection rules of the SMI<sup>®</sup> are extraordinarily included in the SMI<sup>®</sup> on their second trading day and the SMI<sup>®</sup> is adjusted with the free-float market capitalization at the close of the first trading day. The extraordinary inclusion of a newly listed instrument in the SMI<sup>®</sup> can lead to an extraordinary replacement of an existing index component. Extraordinary inclusions are usually implemented after a notification period of 5 trading days. The adjusted cap factors are implemented after a notification period of generally 5 trading days, but no less than one trading day.

If an IPO of a real estate instrument leads to an extraordinary inclusion, it is included in the SMI<sup>®</sup> in three equal stages. This is achieved by the gradual increase of the number of shares or the free-float factor over three trading days starting on the second trading day after the IPO.

<br> Buffered Index Return Notes A-4

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

In case of a planned delisting, the exclusion of an index component is made, if possible, on the next ordinary index review date. However, if the delisting would be effective before the ordinary index review, the component is excluded from the SMI<sup>®</sup> on the effective date of the delisting. If the index component no longer meets the criteria for remaining in the SMI<sup>®</sup> due to a pending acquisition, it may be removed ahead of time. If a component is excluded from the SMI<sup>®</sup> outside of the ordinary index review, it is replaced by the best-ranked candidate on the selection list that is not yet part composition of the SMI<sup>®</sup> in order to maintain a stable number of components within the SMI<sup>®</sup>. Extraordinary exclusions and respective additions are implemented after a notification period of usually 5 trading days. Adjusted cap factors are implemented after a notification period of generally 5 trading days, but no less than one trading day.

Extraordinary inclusions in the SMI<sup>®</sup> take place if the selection rules for the SMI<sup>®</sup> are fulfilled after a three-month period. This occurs on a quarterly basis after the close of trading on the third Friday of March, June, September and December as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Latest Listing Date** | &nbsp;&nbsp; **Earliest Extraordinary Inclusion Date** |
| &nbsp;&nbsp; 5 trading days prior to the end of November | &nbsp;&nbsp; March |
| &nbsp;&nbsp; 5 trading days prior to the end of February | &nbsp;&nbsp; June |
| &nbsp;&nbsp; 5 trading days prior to the end of May | &nbsp;&nbsp; September |
| &nbsp;&nbsp; 5 trading days prior to the end of August | &nbsp;&nbsp; December |

---

In the case of major market changes as a result of a corporate action, an instrument may be admitted to the SMI<sup>®</sup> outside of the accepted admission period as long as it clearly fulfills the selection rules for the SMI<sup>®</sup>. For the same reasons, a component can be excluded if the requirements for admission to the SMI<sup>®</sup> are no longer fulfilled.

**Calculation of the SMI**<sup>®</sup>

The SMI<sup>®</sup> is calculated using the Laspeyres method with the weighted arithmetic mean of a defined number of securities issues. The formula for calculating the level of the SMI<sup>®</sup> can be expressed as follows:

![](image11.gif)

The "free-float market capitalization of the SMI<sup>®</sup>" is equal to the sum of the products, for each component, of the last-paid price, number of shares, free-float factor, capping factor and, if applicable, the current Swiss franc exchange rate as of the time the SMI<sup>®</sup> is being calculated.

The divisor is a technical number used to calculate the SMI<sup>®</sup>. If the market capitalization changes due to a corporate event, the divisor changes while the index level remains the same. The new divisor is calculated on the evening of the day before the corporate event takes effect.

In calculating the SMI<sup>®</sup>, the last available price is taken into account. If no price has been paid on the day of calculation, the previous day's price is used. Only the prices achieved via the electronic order book of the SIX Swiss Exchange are used.

The trading hours for Swiss equities, participation certificates and bonus certificates are determined by the SIX Swiss Exchange. Since the opening phase usually causes strong price fluctuations, the SMI<sup>®</sup> is first calculated two minutes after the start of on order book trading. This index level is called the "open." A closing auction takes place ten minutes before close of trading. At the close of trading, the final closing prices used in calculating the closing level of the SMI<sup>®</sup> are established.

*Component Weighting*

The SMI<sup>®</sup> is weighted by the free-float market capitalization of its components. The number of shares and the free-float factor are reviewed on a quarterly basis. In the same context, each component of the SMI<sup>®</sup> with a free-float market capitalization larger than 18% of the total market capitalization of the SMI<sup>®</sup> is capped to that weight of 18%.

Additionally, the components of the SMI<sup>®</sup> are capped to 18% between two ordinary index reviews as soon as two components exceed a weight of 20% each. If such an intra quarter breach is observed after the close of markets, the new cap factors are calculated so that any component has a maximum weight of 18%. This cap factor is set to be effective after the close of the following trading day.

If an issuer has issued more than one equity instrument (*e.g.*, registered shares, bearer shares, participation certificates, bonus certificates), it is possible that one issuer is represented in the SMI<sup>®</sup> with more than one instrument. In this case, the free-float market capitalization of those instruments is cumulated for the calculation of the cap factors. If the cumulated index weight exceeds the 18%

<br> Buffered Index Return Notes A-5

------

<br> <u> Leveraged Index Return Notes<sup>®</sup> Linked to the Worst-Performing of the EURO STOXX 50<sup>®</sup> Index and the Swiss Market Index due March , 2029 </u>  

threshold, the weight is capped accordingly. The cumulated, capped index weight is distributed proportionally based on the free-float market capitalization of those instruments.

**License Agreement**

JPMorgan Chase & Co. or its affiliate has entered into an agreement with SSE providing it and certain of its affiliates or subsidiaries, including JPMorgan Financial, with a non-exclusive license and, for a fee, with the right to use the SMI<sup>®</sup>, which is owned and published by SSE, in connection with certain securities, including the notes.

SSE and its licensors (the "**Licensors**") have no relationship with the Issuer or the Guarantor (if applicable), other than the licensing of the SMI<sup>®</sup> and the related trademarks for use in connection with the notes.

The notes are not in any way sponsored, endorsed, sold or promoted by SSE, and SSE makes no warranty or representation whatsoever, express or implied, either as to the results to be obtained from the use of the SMI<sup>®</sup> and/or the figure at which the SMI<sup>®</sup> stands at any particular time on any particular day or otherwise. However, SSE shall not be liable (whether in negligence or otherwise) to any person for any error in the SMI<sup>®</sup> and SSE shall not be under any obligation to advise any person of any error therein. The Swiss Market Index<sup>®</sup> and SMI<sup>®</sup> are registered trademarks of SSE which are used under license.

SSE is not responsible for, and has not participated in the determination of, the terms, prices or amount of the notes and will not be responsible for, or participate in, any determination or calculation regarding any amount payable on the notes payable. SSE has no obligation or liability in connection with the administration, marketing or trading of the notes.

The SMI<sup>®</sup> is compiled and calculated by SSE. However, SSE shall not be liable (whether in negligence or otherwise) to any person for any error in the SMI<sup>®</sup>, and SSE shall not be under any obligation to advise any person of any error therein.

SSE is under no obligation to continue the calculation and dissemination of the SMI<sup>®</sup>. SSE determines, composes and calculates the SMI<sup>®</sup> without regard to the notes. SSE has no obligation to take into account your interest, or that of anyone else having an interest, in the notes in determining, composing or calculating the SMI<sup>®</sup>.

<br> Buffered Index Return Notes A-6